Challenges in treatment of hepatitis C among patients with hepatocellular carcinoma

Affiliations

¹ The Johns Hopkins University School of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD.
² The Johns Hopkins University School of Medicine, Division of Infectious Disease, Baltimore, MD.
³ The Johns Hopkins University, Department of Transplant Surgery, Baltimore, MD.

Behnam Saberi et al. Hepatology. 2017 Aug.

. 2017 Aug;66(2):661-663.

doi: 10.1002/hep.29126. Epub 2017 Jun 24.

¹ The Johns Hopkins University School of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD.
² The Johns Hopkins University School of Medicine, Division of Infectious Disease, Baltimore, MD.
³ The Johns Hopkins University, Department of Transplant Surgery, Baltimore, MD.

No abstract available

Comment in

Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?
Ji F, Yeo YH, Wei MT, Wei B, Dang S, Li Z, Nguyen MH. Ji F, et al. Hepatology. 2018 Mar;67(3):1180-1182. doi: 10.1002/hep.29701. Epub 2018 Jan 30. Hepatology. 2018. PMID: 29194694 No abstract available.
Reply.
Saberi B, Dadabhai AS, Durand CM, Philosophe B, Cameron AM, Sulkowski MS, Gurakar A. Saberi B, et al. Hepatology. 2018 Mar;67(3):1183-1184. doi: 10.1002/hep.29703. Epub 2018 Jan 30. Hepatology. 2018. PMID: 29205427 No abstract available.